Viewing Study NCT02859766


Ignite Creation Date: 2025-12-24 @ 4:43 PM
Ignite Modification Date: 2026-03-21 @ 10:41 AM
Study NCT ID: NCT02859766
Status: COMPLETED
Last Update Posted: 2018-02-08
First Post: 2016-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD
Sponsor: Allergan
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 150998-012
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators